Loading clinical trials...
Loading clinical trials...
The study is meant to run parallel to the larger study, RESET. The goal of this study is to to evaluate the effectiveness of a once-off general and personality-tailored text message on GP consultation among RESET participants identified to have high LDL-C. The main question it aims to answer is: Will participants exposed to personality tailored advice have a higher adherence to GP consultation compared to the participants in the control group? Researchers will compare a personalized message to a general message (with no personalization according to patients personality type) and control group to see if drug the messages increase adherence. Participants are required to complete two questionnaires: one before and one after they receive their RESET results.
Age
21 - 65 years
Sex
ALL
Healthy Volunteers
No
National University of Singapore, Yong Loo Lin School of Medicine
Singapore, Singapore, Singapore
Start Date
November 25, 2025
Primary Completion Date
January 1, 2028
Completion Date
November 1, 2028
Last Updated
February 17, 2026
3,000
ESTIMATED participants
General Message
BEHAVIORAL
Personalized Message
BEHAVIORAL
Lead Sponsor
National University Health System, Singapore
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05732779